Similar articles

• Leucocyte movement and colchicine treatment in Behcet's disease.

  Matsumura N, Mizushima Y. Matsumura N, et al. Lancet. 1975 Oct 25;2(7939):813. doi: 10.1016/s0140-6736(75)80031-6. Lancet. 1975. PMID: 78172 No abstract available.
• [Behçet's disease. Circulating immune complexes and abnormalities of polynuclear chemotaxis].

  Graisely B, Margueritte-Renard O, Cloarec M, Debray J. Graisely B, et al. Nouv Presse Med. 1979 Mar 10;8(11):867. Nouv Presse Med. 1979. PMID: 450661 French. No abstract available.
• Arthropathy of Behcet's disease with marked synovial pleocytosis responsive to colchicine.

  Frayha RA. Frayha RA. Arthritis Rheum. 1982 Feb;25(2):235-6. doi: 10.1002/art.1780250221. Arthritis Rheum. 1982. PMID: 7066056 No abstract available.
• Use of colchicine in Behçet's syndrome.

  Sander HM, Randle HW. Sander HM, et al. Cutis. 1986 May;37(5):344-8. Cutis. 1986. PMID: 3519102 Review.
• Major arterial involvement and review of Behcet's disease.

  Alpagut U, Ugurlucan M, Dayioglu E. Alpagut U, et al. Ann Vasc Surg. 2007 Mar;21(2):232-9. doi: 10.1016/j.avsg.2006.12.004. Ann Vasc Surg. 2007. PMID: 17349371 Review.